Abstract:Vaccination is the most effective method for the prevention of COVID-19 caused by SARS-CoV-2, which is still a global epidemic. However, the evolution of SARS-CoV-2 is so rapid that various variants, including the Alpha, Beta, Gamma, Delta, and Omicron variants, have emerged, lowering the protection rate of vaccines and even resulting in breakthrough infections. Additionally, some rare but severe adverse reactions induced by COVID-19 vaccines may raise safety concerns and hinder vaccine promotion; however, clinical studies have shown that the benefits of vaccination outweigh the risks caused by adverse reactions. Current vaccines approved with emergency use authorization (EUA) were originally adaptive for adults only, and infants, children, and adolescents are not included. New-generation vaccines are needed to overcome the challenges of limited adaptive age population, breakthrough infection (mainly due to virus variant emergencies), and critical adverse reactions. Fortunately, some advances in COVID-19 vaccines have been obtained regarding enlarged adaptive populations for clinical applications, such as the Pfizer/BioNTech vaccine and the Moderna vaccine. In this article, we provide a review on the challenges and recent advancements in COVID-19 vaccines. The development of next-generation COVID-19 vaccines should lay emphasis on the expansion of adaptive age populations in all individuals, the induction of immune responses to viral variants, the avoidance or alleviation of rare but potentially critical adverse reactions, and the discovery of subunit vaccines with adjuvants encapsulated in nanoparticles.

Broad-spectrum pan-genus and pan-family virus vaccines

Advances in Post-Pandemic Viral Antigen Production for Vaccines

Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines

Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants

Challenges and developments in universal vaccine design against SARS-CoV-2 variants

Next-generation COVID-19 Vaccines: Opportunities for Vaccine Development and Challenges in Tackling COVID-19

Advances in virus-like particle-based SARS-CoV-2 vaccines

Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing

Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses

COVID‐19 vaccine: recent advancements and future prospects

Severe acute respiratory syndrome coronavirus 2 variants-Possibility of universal vaccine design: A review

Progress and perspectives of universal influenza vaccine

Engineering Antiviral Vaccines

Challenges and Recent Advancements in COVID-19 Vaccines

Progress towards the Development of a Universal Influenza Vaccine

Mucosal vaccines for viral diseases: Status and prospects

Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Viral Vector Vaccine Development and Application during the COVID-19 Pandemic

Coronavirus vaccine development: from SARS and MERS to COVID-19

Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics